Introduction Genital warts are caused by infection with human papillomavirus (HPV) and are
associated with significant morbidity. Primary prevention of genital warts is possible through …

We estimated the prevalence of and costs associated with genital warts among privately
insured individuals from the perspective of a private health plan in the United States. Health …

The anogenital human papillomavirus (HPV) is estimated to be the most commonly
occurring sexually transmitted infection in the US. Comprehensive estimates of the annual …

Objectives To estimate the cost of six different techniques used to treat Genital Warts and the
annual average cost of treating a typical GW patient in Peru. To estimate the annual …

Background Many economic evaluations of human papillomavirus vaccination should
ideally consider multiple disease outcomes, including anogenital warts, respiratory …

Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …

Background The total direct cost of screening and treating all human papillomavirus-related
diseases (HPV-RD) has not been measured in a single study. Accurate cost estimates are …

Background: Data on the burden of genital warts in terms of treatment costs and detriment to
quality of life (QoL) are required to assess cost-effectiveness of quadrivalent human …

Estimates of medical care costs for cervical and other cancers associated with human
papillomavirus (HPV) are higher in studies published in recent years than in studies …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …